Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-12-04

Clinical Trial Update: Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid [Phase 2]

View source ↗

Summary

Phase 2 study evaluating leflunomide in combination with topical corticosteroids for bullous pemphigoid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Bullous Pemphigoid | Phase 2 | Status: UNKNOWN